Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

118 Press Releases
DateTitleCompany
19 Dec 14 Ligand Partner Pfizer Receives European Marketing Authorization for DUAVIVE® (Conjugated Estrogens/Bazedoxifene) for Treatment of Estrogen Deficiency Symptoms in Postmenopausal Women with a Uterus Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
12 Nov 14 Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission for Severe Aplastic Anemia Indication for Revolade™ (eltrombopag) Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
16 Oct 14 Ligand to Host Analyst Day on November 18th in New York City Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
08 Oct 14 Ligand Reports Third Quarter Revenues and Expected Diluted EPS Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
26 Sep 14 Ligand Earns Milestone Payment Triggered by EU Approval of Merck’s Captisol-enabled NOXAFIL® (posaconazole) Concentrate for Solution for Infusion Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
09 Sep 14 Ligand Licenses Captisol-enabled™ Lamotrigine to CURx Pharmaceuticals Inc. Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
11 Aug 14 Ligand Announces Proposed Offering of $225 Million of Convertible Senior Notes and Announces $200 Million Share Repurchase Program Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
17 Jul 14 Ligand Reports Second Quarter Revenues and Announces Share Repurchase Program Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
14 Jul 14 Ligand Chairman Dr. John W. Kozarich Named Director of the Year Honoree by Corporate Directors Forum Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
24 Jun 14 Ligand Signs Global License Agreement with TG Therapeutics for IRAK-4 Inhibitor Program Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
23 Jun 14 Ligand to Participate in ROTH Capital Partners’ Healthcare Corporate Access Day in London Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
16 Jun 14 Ligand Announces Successful First-in-Human Trial Results for Glucagon Program Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
12 May 14 Ligand Earns Milestone from SAGE Therapeutics for SAGE-547 Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
23 Apr 14 Ligand’s Partner Spectrum Pharmaceuticals Reports Captisol-Enabled Melphalan Meets Primary Endpoint in Pivotal Trial Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
23 Apr 14 Ligand to Participate in Three Upcoming Investor Conferences Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
22 Apr 14 Ligand to Report First Quarter Results on May 7th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
17 Mar 14 Ligand Earns $1 Million Milestone Payment Triggered by FDA Approval of Merck’s NOXAFIL® (posaconazole) Injection for Intravenous Use, a New Captisol-enabled Formulation Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
10 Mar 14 Captisol® Licensee Lundbeck Announces FDA Acceptance of NDA Submission for Carbamazepine IV Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
28 Feb 14 Ligand Partner GlaxoSmithKline Submits U.S. Regulatory Application for Promacta® (eltrombopag) for Severe Aplastic Anaemia Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
10 Feb 14 Ligand to Receive $1 Million Kyprolis® Commercial Milestone Payment from Onyx Pharmaceuticals Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
03 Feb 14 Ligand Partner GlaxoSmithKline Gains FDA Breakthrough Therapy Designation for Promacta®/Revolade® for Severe Aplastic Anemia Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
29 Jan 14 Ligand to Report Fourth Quarter Results on February 11th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
09 Dec 13 Ligand Announces Positive Preclinical Data on Small-Molecule G-CSF Receptor Agonist at the 55th Annual Meeting of the American Society of Hematology Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
12 Nov 13 Ligand Initiates Phase 1 Trial with Glucagon Receptor Antagonist for Type 2 Diabetes Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
07 Nov 13 Reminder: Ligand to Host Analyst Day on November 14th in Chicago Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
14 Oct 13 Ligand to Host Analyst Day on November 14th in Chicago Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
09 Oct 13 Ligand to Report Third Quarter Results on October 30th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
07 Oct 13 Ligand Announces FDA Acceptance of Investigational New Drug Application for Glucagon Receptor Antagonist Program Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
03 Oct 13 Ligand Partner Pfizer Receives FDA Approval for DUAVEETM for the Treatment of Moderate-to-Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause and the Prevention of Postmenopausal Osteoporosis Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
24 Sep 13 Ligand Partner GSK Receives Marketing Authorization from the European Commission for Additional Revolade™ (Eltrombopag) Indication as the First Approved Treatment for Chronic Hepatitis C-Associated Thrombocytopenia Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.